Interim study results indicate that patients receiving Rotation Medical’s Bioinductive Implant to treat rotator cuff disease reported statistically significant improvement at six months.
Seikagaku entered into a basic co-development and marketing collaboration with Ono Pharmaceutical in Japan for SI-613 for the treatment of osteoarthritis.
XpandOrtho received FDA 510(k) clearance for an electronic soft tissue balancing instrument for total knee replacement that is compatible with almost all total knee systems from major manufacturers.